Literature DB >> 16054976

Mechanisms of alcohol-associated cancers: introduction and summary of the symposium.

Vishnudutt Purohit1, Jag Khalsa, Jose Serrano.   

Abstract

Chronic alcohol consumption is associated with an increased risk for cancers of many organs, such as oral cavity, pharynx, larynx, and esophagus; breast; liver; ovary; colon; rectum; stomach; and pancreas. An understanding of the underlying mechanisms by which chronic alcohol consumption promotes carcinogenesis is important for development of appropriate strategies for prevention and treatment of alcohol-associated cancers. The National Institute on Alcohol Abuse and Alcoholism, Office of Dietary Supplements, Office of Rare Diseases, National Cancer Institute, National Institute on Drug Abuse, and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, sponsored an international symposium on Mechanisms of Alcohol-Associated Cancers in Bethesda, Maryland, USA, October 2004. The following is a summary of the symposium. Chronic ethanol consumption may promote carcinogenesis by (1) production of acetaldehyde, which is a weak mutagen and carcinogen; (2) induction of cytochrome P450 2E1 and associated oxidative stress and conversion of procarcinogens to carcinogens; (3) depletion of S-adenosylmethionine and, consequently, induction of global DNA hypomethylation; (4) induction of increased production of inhibitory guanine nucleotide regulatory proteins and components of extracellular signal-regulated kinase-mitogen-activated protein kinase signaling; (5) accumulation of iron and associated oxidative stress; (6) inactivation of the tumor suppressor gene BRCA1 and increased estrogen responsiveness (primarily in breast); and (7) impairment of retinoic acid metabolism. Nicotine may promote carcinogenesis through activation of extracellular signal-regulated kinase/cyclooxygenase-2/vascular endothelial growth factor signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054976     DOI: 10.1016/j.alcohol.2005.05.001

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  32 in total

1.  Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.

Authors:  Ya-Ping Luo; Han-Chun Chen; Md Asaduzzaman Khan; Fang-Zhi Chen; Xin-Xing Wan; Bo Tan; Fang-Dan Ou-Yang; Dian-Zheng Zhang
Journal:  Tumour Biol       Date:  2010-09-29

2.  Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women's Health Initiative.

Authors:  Jessica T Kubo; Michael T Henderson; Manisha Desai; Jean Wactawski-Wende; Marcia L Stefanick; Jean Y Tang
Journal:  Cancer Causes Control       Date:  2013-10-31       Impact factor: 2.506

3.  Lipidomic changes in rat liver after long-term exposure to ethanol.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Shakuntala Kondraganti; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

4.  ERα mediates alcohol-induced deregulation of Pol III genes in breast cancer cells.

Authors:  Qingsong Zhang; Jian Jin; Qian Zhong; Xiaoli Yu; Daniel Levy; Shuping Zhong
Journal:  Carcinogenesis       Date:  2012-10-10       Impact factor: 4.944

5.  ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.

Authors:  Harshica Fernando; Shakuntala Kondraganti; Kamlesh K Bhopale; David E Volk; Muniasamy Neerathilingam; Bhupendra S Kaphalia; Bruce A Luxon; Paul J Boor; G A Shakeel Ansari
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

6.  Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.

Authors:  Sarah McNabb; Tabitha A Harrison; Demetrius Albanes; Sonja I Berndt; Hermann Brenner; Bette J Caan; Peter T Campbell; Yin Cao; Jenny Chang-Claude; Andrew Chan; Zhengyi Chen; Dallas R English; Graham G Giles; Edward L Giovannucci; Phyllis J Goodman; Richard B Hayes; Michael Hoffmeister; Eric J Jacobs; Amit D Joshi; Susanna C Larsson; Loïc Le Marchand; Li Li; Yi Lin; Satu Männistö; Roger L Milne; Hongmei Nan; Christina C Newton; Shuji Ogino; Patrick S Parfrey; Paneen S Petersen; John D Potter; Robert E Schoen; Martha L Slattery; Yu-Ru Su; Catherine M Tangen; Thomas C Tucker; Stephanie J Weinstein; Emily White; Alicja Wolk; Michael O Woods; Amanda I Phipps; Ulrike Peters
Journal:  Int J Cancer       Date:  2019-06-07       Impact factor: 7.396

7.  Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.

Authors:  Katsutoshi Tokushige; Etsuko Hashimoto; Yoshinori Horie; Makiko Taniai; Susumu Higuchi
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

8.  Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease.

Authors:  Blair U Bradford; Thomas M O'Connell; Jun Han; Oksana Kosyk; Svitlana Shymonyak; Pamela K Ross; Jason Winnike; Hiroshi Kono; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-12       Impact factor: 4.219

9.  Consumption of alcohol and risk of cancer among men: a 30 year cohort study in Lithuania.

Authors:  Ruta Everatt; Abdonas Tamosiunas; Dalia Virviciute; Irena Kuzmickiene; Regina Reklaitiene
Journal:  Eur J Epidemiol       Date:  2013-05-23       Impact factor: 8.082

10.  CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.

Authors:  Chang-Ming Gao; Toshiro Takezaki; Jian-Zhong Wu; Min-Bin Chen; Yan-Ting Liu; Jian-Hua Ding; Haruhiko Sugimura; Jia Cao; Nobuyuki Hamajima; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.